XML 87 R70.htm IDEA: XBRL DOCUMENT v3.19.3
Supplemental Guarantor Information (Supplemental Condensed Consolidated Statement Of Cash Flows) (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Dec. 31, 2018
USD ($)
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by/(used in) operating activities $ (148,964) $ (216,997)  
Net cash provided by/(used in) investing activities (11,555) (39,657)  
Financing activities      
Borrowings under revolving credit facilities 1,184,800 520,000  
Payments on revolving credit facilities (1,108,500) (284,000)  
Extinguishments of debt assumed in business combination   (94,231)  
Proceeds from issuance of senior notes due 2027 500,000    
Extinguishment of senior notes due 2022 (391,942)    
Debt issuance costs (6,075) (3,521)  
Proceeds from issuance of insurance premium notes and other 12,629 11,838  
Principal payments on insurance notes payable and other (19,275) (2,173)  
Net payments on mortgage repurchase facilities (26,757) 9,008  
Net proceeds from issuances of common stock 25,817 31,230  
Repurchases of common stock upon vesting of stock based compensation (3,588) (5,483)  
Repurchases of common stock under our stock repurchase program (1,439)    
Net cash provided by (used in) financing activities 165,670 182,668  
Net increase (decrease) 5,151 (73,986)  
Cash and cash equivalents and Restricted cash, Beginning of period 36,441 93,713  
Cash and cash equivalents and Restricted cash, End of period 41,592 19,727  
Cash and cash equivalents 38,508 15,927 $ 32,902
Restricted Cash 3,084 3,800  
Elimination Entries [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by/(used in) operating activities   (16,580)  
Net cash provided by/(used in) investing activities 142,391 280,048  
Financing activities      
Payments from (and advances to) parent/subsidiary (142,391) (280,048)  
Net cash provided by (used in) financing activities (142,391) (280,048)  
Net increase (decrease)   (16,580)  
Cash and cash equivalents and Restricted cash, End of period   (16,580)  
Cash and cash equivalents   (16,580)  
Century [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by/(used in) operating activities (52,863) (71,743)  
Net cash provided by/(used in) investing activities (146,499) (153,607)  
Financing activities      
Borrowings under revolving credit facilities 1,184,800 520,000  
Payments on revolving credit facilities (1,108,500) (284,000)  
Extinguishments of debt assumed in business combination   (94,231)  
Proceeds from issuance of senior notes due 2027 500,000    
Extinguishment of senior notes due 2022 (391,942)    
Debt issuance costs (6,075) (3,521)  
Principal payments on insurance notes payable and other   (9)  
Net proceeds from issuances of common stock 25,817 31,230  
Repurchases of common stock upon vesting of stock based compensation (3,588) (5,483)  
Repurchases of common stock under our stock repurchase program (1,439)    
Payments from (and advances to) parent/subsidiary   5,130  
Net cash provided by (used in) financing activities 199,073 169,116  
Net increase (decrease) (289) (56,234)  
Cash and cash equivalents and Restricted cash, Beginning of period 2,183 56,234  
Cash and cash equivalents and Restricted cash, End of period 1,894    
Cash and cash equivalents 1,894   2,183
Guarantor Subsidiaries [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by/(used in) operating activities (112,548) (123,418)  
Net cash provided by/(used in) investing activities (7,610) (165,939)  
Financing activities      
Proceeds from issuance of insurance premium notes and other 12,629 11,838  
Principal payments on insurance notes payable and other (19,275) (2,164)  
Payments from (and advances to) parent/subsidiary 125,834 263,120  
Net cash provided by (used in) financing activities 119,188 272,794  
Net increase (decrease) (970) (16,563)  
Cash and cash equivalents and Restricted cash, Beginning of period 4,006 28,044  
Cash and cash equivalents and Restricted cash, End of period 3,036 11,481  
Cash and cash equivalents 2,125 8,922 2,101
Restricted Cash 911 2,559  
Non Guarantor Subsidiaries [Member]      
Condensed Cash Flow Statements, Captions [Line Items]      
Net cash provided by/(used in) operating activities 16,447 (5,256)  
Net cash provided by/(used in) investing activities 163 (159)  
Financing activities      
Net payments on mortgage repurchase facilities (26,757) 9,008  
Payments from (and advances to) parent/subsidiary 16,557 11,798  
Net cash provided by (used in) financing activities (10,200) 20,806  
Net increase (decrease) 6,410 15,391  
Cash and cash equivalents and Restricted cash, Beginning of period 30,252 9,435  
Cash and cash equivalents and Restricted cash, End of period 36,662 24,826  
Cash and cash equivalents 34,489 23,585 $ 28,618
Restricted Cash $ 2,173 $ 1,241